✦ LIBER ✦

Beta cell destruction in the development of autoimmune diabetes in the non-obese diabetic (NOD) mouse

✍ Scribed by Helen E. Thomas; Thomas W. H. Kay

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 140 KB
Volume: 16
Category: Article
ISSN: 1520-7552
DOI: 10.1002/1520-7560(200007/08)16:4<251::aid-dmrr126>3.0.co;2-c

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Contribution of T cells to the developme

Contribution of T cells to the development of autoimmune diabetes in the NOD mouse model

✍ Hiroo Toyoda; Bent Formby 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 1 views

The nonobese diabetic (NOD) mouse spontaneously develops an autoimmune diabetes that shares many immunogenetic features with human insulin-dependent diabetes mellitus (IDDM), type 1 diabetes. The mononuclear cell infiltrates in the islet, which results in the development of insulitis (a prerequisite

Nicotinamide prevents the development of

Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis

✍ O'Brien, Bronwyn A.; Harmon, Brian V.; Cameron, Donald P.; Allan, David J. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB 👁 2 views

The development of diabetes in non-obese diabetic (NOD) mice, which normally takes between 3 and 7 months, can be accelerated by cyclophosphamide (CY) injections, with rapid progression to diabetes within only 2±3 weeks. This insulin-dependent diabetes mellitus (IDDM) can be prevented or delayed in

Diet can influence the ability of nicoti

Diet can influence the ability of nicotinamide to prevent diabetes in the non-obese diabetic mouse: a preliminary study

✍ P.E. Beales; L.A. Burr; G.P. Webb; K.J. Mansfield; P. Pozzilli 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

Background The non-obese diabetic (NOD) mouse is a widely used model of Type 1 diabetes mellitus (Type 1 DM), which displays many of the characteristics of the disease found in humans. Nicotinamide (NA) is currently being tested in large-scale, multi-centre human trials for the prevention of Type 1

Autoimmune insulitis and diabetes in the

Autoimmune insulitis and diabetes in the absence of antigen-specific contact between T cells and β-islet cells

✍ Adelaida Sarukhan; Oskar Lechner; Harald von Boehmer 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

Poor Beta-cell Function After the Clinic

Poor Beta-cell Function After the Clinical Manifestation of Type 1 Diabetes in Children Initially Positive for Islet Cell Specific Autoantibodies

✍ Komulainen, J.; Knip, M.; Lounamaa, R.; Vähäsalo, P.; Karjalainen, J.; Sabbah, E 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 1 views

The prognostic significance of islet cell specific autoantibodies at the diagnosis of Type 1 (insulin-dependent) diabetes mellitus for the persistence of residual beta-cell function over the first 2 years of clinical disease was evaluated in a prospective population-based study. Seven hundred and ei

Beta-cell deterioration determines the o

Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in Type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study

✍ Levy, J.; Atkinson, A.B.; Bell, P.M.; McCance, D.R.; Hadden, D.R. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

Secondary failure of plasma glucose control following initial successful response to diet therapy may be due to dietary indiscretion, or to progression of the intrinsic diabetic condition. We report a 10-year prospective natural history study of 432 newly diagnosed diabetic patients aged 40-69 years